Effects of hepatocyte growth factor-mediated activation of Dll4-Notch-Hey2 signaling pathway

Chinese Medical Journal

Volumn 124, Issue 1, 2011, Pages 127-131

  Gao, Yu Fang ^b   Ha, Xiao Qin ^a   de Lü, Tang ^a   Han, Juan Ping ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

^b Central Hospital of Xianyang   (China)

Author keywords

Cell migration; Cell proliferation; Genetic transcription; Hepatocyte growth factor

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOVIRUS VECTOR; DELTA LIKE 4 PROTEIN; NOTCH1 RECEPTOR; RECOMBINANT SCATTER FACTOR; REGULATOR PROTEIN; SCATTER FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HEY2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTORS, NOTCH; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 78651246096     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.01.023     Document Type: Article

References (21)

1. Eccles SA, Court W, Patterson L, Sanderson S. In vitro assays for endothelial cell functions related to angiogenesis: proliferation, motility, tubular differentiation, and proteolysis. Methods Mol Biol 2009; 467: 159-181.
2. De Smet F, Segura I, De Bock K, Hohensinner PJ, Carmeliet P. Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler Thromb Vasc Biol 2009; 29: 639-649.
3. Qutub AA, Popel AS. Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting. BMC Syst Biol 2009; 3: 13.
4. Staton CA, Reed MW, Brown NJ. A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol 2009; 90: 195-221.
5. Cai L, Johnstone BH, Cook TG, Liang Z, Traktuev D, Cornetta K, et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 2007; 25: 3234-3243.
6. Guo YH, He JG, Wu JL, Yang L, Zhang DS, Tan XY, et al. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. Cytotherapy 2008; 10: 857-867.
7. Bell LN, Cai L, Johnstone BH, Traktuev DO, March KL, Considine RV. A central role for hepatocyte growth factor in adipose tissue angiogenesis. Am J Physiol Endocrinol Metab 2008; 294: E336-E344.
8. Aoki M, Morishita R, Taniyama Y, Kida I, Moriguchi A, Matsumoto K, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther 2000; 7: 417-427.
9. Ha XQ, Ren JP, Bi JJ, Zhang JH, Wu ZZ. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in dog hindlimb ischemia models. Chin Sci Bull 2003; 48: 676-680
10. Wu DL, Zhang YR, Lao MF, Qiu ZH, Ha XQ, Wu ZZ. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat myocardial ischemia models. Chin Sci Bull 2003; 48: 273-276.
11. Ha X, Yuan B, Li Y, Lao M, Wu Z. Gene therapy for pathological scar with hepatocyte growth factor mediated by recombinant adenovirus vector. Sci China C Life Sci 2003; 46: 320-327.
12. Ha X, Li Y, Lao M, Yuan B, Wu CT. Effect of human hepatocyte growth factor on promoting wound healing and preventing scar formation by adenovirus-mediated gene transfer. Chin Med J 2003; 116: 1029-1033.
13. Kadesch T. Notch signaling: the demise of elegant simplicity. Curr Opin Genet Dev 2004; 14: 506-512.
14. Cao L, Arany PR, Wang YS, Mooney DJ. Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. Biomaterials 2009; 30: 4085-4093.
15. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 2000; 14: 1343-1352.
16. Mailhos C, Modlich U, Lewis J, Harris A, Bicknell R, Ish-Horowicz D. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 2001; 69: 135-144.
17. Diez H, Fischer A, Winkler A, Hu CJ, Hatzopoulos AK, Breier G, et a1. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 2007; 313: 1-9.
18. Liu ZJ, Shirakawa T, Li Y, Soma A, Oka M, Dotto GP, et al. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 2003; 23: 14-25.
19. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, et al. Inhibition of Dll4 mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 2007; 109: 4753-4760.
20. Hellström M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, et al. Dll4 signaling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007; 445: 776-780.
21. Taylor KL, Henderson AM, Hughes CC. Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvasc Res 2002; 64: 372-383.